BRK-B vs HBAN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HBAN presents a mixed profile with a stable Piotroski F-Score of 4/9 and a Graham Number of $20.76 suggesting significant defensive undervaluation relative to its current price of $16.38. While the bank maintains a healthy dividend payout ratio and consistent historical earnings beats, there is a concerning divergence between revenue growth (+10.30%) and earnings growth (-10.90%). The technical trend is currently bearish (0/100), and the intrinsic growth-based value ($9.73) suggests the market is pricing in premiums that the current earnings trajectory does not fully support.
Compare Another Pair
Related Comparisons
BRK-B vs HBAN: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Huntington Bancshares Incorporated (HBAN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.